Search hospitals > Delaware > Frankford

Beebe South Coastal Health Campus

Claim this profile
Frankford, Delaware 19945
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
97 reported clinical trials
1 medical researcher
Photo of Beebe South Coastal Health Campus in FrankfordPhoto of Beebe South Coastal Health Campus in FrankfordPhoto of Beebe South Coastal Health Campus in Frankford

Summary

Beebe South Coastal Health Campus is a medical facility located in Frankford, Delaware. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Beebe South Coastal Health Campus is involved with conducting 97 clinical trials across 226 conditions. There are 1 research doctors associated with this hospital, such as Gregory A. Masters.

Area of expertise

1Cancer
Global Leader
Beebe South Coastal Health Campus has run 38 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Beebe South Coastal Health Campus has run 23 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 positive
HER2 negative

Top PIs

Clinical Trials running at Beebe South Coastal Health Campus

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Gastroesophageal Junction Adenocarcinoma
Colorectal Cancer
Gastric Cancer
Anal Cancer
Small Cell Lung Cancer
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Image of trial facility.

Support Program

for Breast Cancer

This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Beebe South Coastal Health Campus?
Beebe South Coastal Health Campus is a medical facility located in Frankford, Delaware. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Beebe South Coastal Health Campus is involved with conducting 97 clinical trials across 226 conditions. There are 1 research doctors associated with this hospital, such as Gregory A. Masters.